Caxton Associates (New York)’s Natera NTRA Stock Holding History

Caxton Associates (New York)’s Portfolio NTRA Stock Details NTRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,912	Closed	-$345K	–	453
2020 Q2	$345K	Buy	+6,912	New	+$277K	0.03%	216

Other funds holding NTRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Caxton Associates (New York)'s NTRA Position: Q3 2020 in Review

Caxton Associates (New York) sold out of Natera (NTRA) in Q3 2020, closing a stake of 6,912 shares — an estimated $345K sold.

Caxton Associates (New York) first reported a position in NTRA in Q2 2020 and held it in 1 quarter. The position peaked at $345K in Q2 2020. 253 funds tracked by Wall St. Rank hold NTRA as of Q3 2020.

Caxton Associates (New York) reported no remaining Natera position as of Q3 2020 after selling out during the quarter.
Caxton Associates (New York) sold 6,912 Natera shares in Q3 2020, an estimated $345K.
Caxton Associates (New York) first reported a position in Natera in Q2 2020 and held it in 1 quarter.
Caxton Associates (New York)'s Natera position peaked at $345K in Q2 2020.
253 funds tracked by Wall St. Rank held Natera as of Q3 2020.

Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.